too soon @Grugg notable news is ethics approval for CPACS trial next couple of weeks.
Then at the AGM announced that Bisantrene may also alledgedly protect organ damage, potential preclinicals underway.
Also CPACS mechanism of action publication in high impact scientific journal.
Dr Meg Baldwin, OPT founder and DR Serge Scrofani CSL appointed non-executive director for Race.
revert back in another 6months things will start getting interesting.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.34 |
Change
-0.015(1.11%) |
Mkt cap ! $231.9M | |||
| Open | High | Low | Value | Volume |
| $1.35 | $1.36 | $1.31 | $132.3K | 98.59K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20000 | $1.32 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.34 | 10069 | 2 |
View Market Depth
| Last trade - 15.54pm 20/06/2025 (20 minute delay) ? |
| RAC (ASX) Chart |